Shuwen Yu
- Molecular Biology
- Immunology top 10%
- Oncology
- Cancer Research top 10%
- Complementary and alternative medicine top 5%
- Co-authors
- Lu WangMin JiangDuxin SunXianhua CaoChang‐Guo ZhanAdel HamzaBing WangTao Zhang
- Topics
- Renal Diseases and Glomerulopathies (8 papers)Chronic Kidney Disease and Diabetes (4 papers)Lung Cancer Treatments and Mutations (4 papers)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Shuwen Yu
46 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 107
- Molecular Biology 670
- Immunology 299
- Oncology 218
- Cancer Research 186
- Complementary and alternative medicine 135
Countries citing papers authored by Shuwen Yu
This map shows the geographic impact of Shuwen Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuwen Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuwen Yu more than expected).
Fields of papers citing papers by Shuwen Yu
This network shows the impact of papers produced by Shuwen Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuwen Yu. The network helps show where Shuwen Yu may publish in the future.
Co-authorship network of co-authors of Shuwen Yu
This figure shows the co-authorship network connecting the top 25 collaborators of Shuwen Yu. A scholar is included among the top collaborators of Shuwen Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuwen Yu. Shuwen Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 4 | |
| 5 | 1 | |
| 6 | 10 | |
| 7 | 4 | |
| 8 | 11 | |
| 9 | 0 | |
| 10 | 4 | |
| 11 | 3 | |
| 12 | PCSK9 promotes the progression and metastasis of colon cancer cells through regulation of EMT and PI3K/AKT signaling in tumor cells and phenotypic polarization of macrophagesbreakdown → | 173 |
| 13 | 1 | |
| 14 | 66 | |
| 15 | 112 | |
| 16 | 105 | |
| 17 | 14 | |
| 18 | 5 | |
| 19 | 20 | |
| 20 | 306 |
About Shuwen Yu
Shuwen Yu is a scholar working on Nephrology, Neurology and Immunology, having authored 49 papers that have together received 1.4k indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (8 papers), Chronic Kidney Disease and Diabetes (4 papers) and Lung Cancer Treatments and Mutations (4 papers). The work is most often cited by research in Complementary and alternative medicine (135 citations), Immunology (299 citations) and Cancer Research (186 citations). Shuwen Yu has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Lu Wang, Min Jiang, Duxin Sun, Xianhua Cao, Chang‐Guo Zhan, Adel Hamza, Bing Wang, Tao Zhang, Qi Long Lu and Shuangshuang Li. Their work appears in journals such as Journal of Clinical Oncology, Brain Research and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.